AbbVie
ABBV
ABBV
2,647 hedge funds and large institutions have $127B invested in AbbVie in 2021 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 1,341 increasing their positions, 872 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
1% less call options, than puts
Call options by funds: $2.19B | Put options by funds: $2.22B
5% less capital invested
Capital invested by funds: $133B → $127B (-$6.15B)
4% less funds holding in top 10
Funds holding in top 10: 139 → 134 (-5)
Holders
2,647
Holding in Top 10
134
Calls
$2.19B
Puts
$2.22B
Top Buyers
| 1 | +$964M | |
| 2 | +$458M | |
| 3 | +$326M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$307M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$262M |
Top Sellers
| 1 | -$1.49B | |
| 2 | -$661M | |
| 3 | -$391M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$301M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$268M |